Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medicinal attributes of 1,2,3-triazoles: Current developments
Divya Dheer, Virender Singh, Ravi Shankar
Bioorganic Chemistry (2017) Vol. 71, pp. 30-54
Closed Access | Times Cited: 765

Showing 26-50 of 765 citing articles:

P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators
Yang Guo, Milad Ashrafizadeh, Murtaza M. Tambuwala, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104161-104161
Closed Access | Times Cited: 22
Design, synthesis, characterization, antimicrobial evaluation and molecular modeling studies of some dehydroacetic acid-chalcone-1,2,3-triazole hybrids
Kashmiri Lal, Pinki Yadav, Ashwani Kumar, et al.
Bioorganic Chemistry (2018) Vol. 77, pp. 236-244
Closed Access | Times Cited: 129
Intermolecular Palladium(0)-Catalyzed Atropo-enantioselective C–H Arylation of Heteroarenes
Qui-Hien Nguyen, Shu‐Min Guo, Titouan Royal, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 5, pp. 2161-2167
Open Access | Times Cited: 127
1,2,3‐Triazole hybrids with anti‐HIV‐1 activity
Lian‐Shun Feng, Man‐Jie Zheng, Feng Zhao, et al.
Archiv der Pharmazie (2020) Vol. 354, Iss. 1
Closed Access | Times Cited: 117
Synthesis, crystal structure and antimicrobial potential of some fluorinated chalcone-1,2,3-triazole conjugates
Pinki Yadav, Kashmiri Lal, Lokesh Kumar, et al.
European Journal of Medicinal Chemistry (2018) Vol. 155, pp. 263-274
Closed Access | Times Cited: 109
Recent developments on triazole nucleus in anticonvulsant compounds: a review
Mingxia Song, Xian‐Qing Deng
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 33, Iss. 1, pp. 453-478
Open Access | Times Cited: 107
1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents
Jingyu Zhang, Su Wang, Yanyan Ba, et al.
European Journal of Medicinal Chemistry (2019) Vol. 174, pp. 1-8
Closed Access | Times Cited: 107
Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure‐activity relationship
Feng Gao, Gang Huang, Jiaqi Xiao
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 2049-2084
Closed Access | Times Cited: 107
Artemisinin-derived hybrids and their anticancer activity
Feng Gao, Zhou Sun, Fangong Kong, et al.
European Journal of Medicinal Chemistry (2020) Vol. 188, pp. 112044-112044
Closed Access | Times Cited: 101
1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)
Zhi Xu
European Journal of Medicinal Chemistry (2020) Vol. 206, pp. 112686-112686
Closed Access | Times Cited: 95
Recent accomplishments on the synthetic/biological facets of pharmacologically active 1H-1,2,3-triazoles
Sumit Kumar, Bharvi Sharma, Vishu Mehra, et al.
European Journal of Medicinal Chemistry (2020) Vol. 212, pp. 113069-113069
Closed Access | Times Cited: 93
1,2,3-Triazoles of 8-Hydroxyquinoline and HBT: Synthesis and Studies (DNA Binding, Antimicrobial, Molecular Docking, ADME, and DFT)
Nidhi Nehra, Ram Kumar Tittal, Vikas D. Ghule
ACS Omega (2021) Vol. 6, Iss. 41, pp. 27089-27100
Open Access | Times Cited: 83
Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies
Ali Oubella, Az‐Eddine El Mansouri, Mourad Fawzi, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105184-105184
Closed Access | Times Cited: 79
Andrographolide: Chemical modification and its effect on biological activities
G. Ravi Kumar, Davinder Singh, Javeed Ahmad Tali, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103511-103511
Closed Access | Times Cited: 78
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents
Pavan Kumar Bangalore, Vagolu Siva Krishna, Rakesh K. Bollikanda, et al.
Journal of Natural Products (2019) Vol. 83, Iss. 1, pp. 26-35
Closed Access | Times Cited: 78
Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses
Nadjet Rezki, Meshal A. Almehmadi, Saleh Ihmaid, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104133-104133
Closed Access | Times Cited: 77
Developments in the Application of 1,2,3-Triazoles in Cancer Treatment
Katerina I. Slavova, Lozan Todorov, Nataliya P. Belskaya, et al.
Recent Patents on Anti-Cancer Drug Discovery (2020) Vol. 15, Iss. 2, pp. 92-112
Closed Access | Times Cited: 71
1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226
Heba F. Ashour, Laila Abou‐Zeid, Magda A.‐A. El‐Sayed, et al.
European Journal of Medicinal Chemistry (2020) Vol. 189, pp. 112062-112062
Closed Access | Times Cited: 70
Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors
Nashwa H. Zaher, Mohammed Ismail Mostafa, Abdulla Al‐Taher
Acta Pharmaceutica (2020) Vol. 70, Iss. 2, pp. 145-159
Open Access | Times Cited: 70
A review on ‘triazoles’: their chemistry, synthesis and pharmacological potentials
Deepali Dixit, Prabhakar Kumar Verma, Rakesh Kumar Marwaha
Journal of the Iranian Chemical Society (2021) Vol. 18, Iss. 10, pp. 2535-2565
Closed Access | Times Cited: 66
Asymmetric Azide–Alkyne Cycloaddition with Ir(I)/Squaramide Cooperative Catalysis: Atroposelective Synthesis of Axially Chiral Aryltriazoles
Xue Zhang, Shunian Li, Wenjing Yu, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 14, pp. 6200-6207
Closed Access | Times Cited: 61
Bioactive 1,2,3‐Triazoles: An Account on their Synthesis, Structural Diversity and Biological Applications
Luana da Silva Magalhães Forezi, Carolina G. S. Lima, Adriane A. P. Amaral, et al.
The Chemical Record (2021) Vol. 21, Iss. 10, pp. 2782-2807
Closed Access | Times Cited: 59
Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability
Saleh Ihmaid, Shaya Y. Al‐Raqa, Mohamed Reda Aouad, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104835-104835
Closed Access | Times Cited: 57
A review on the biomedical efficacy of transition metal triazole compounds
Sajjad Hussain Sumrra, Wardha Zafar, Muhammad Imran, et al.
Journal of Coordination Chemistry (2022) Vol. 75, Iss. 3-4, pp. 293-334
Closed Access | Times Cited: 54
Emerging impact of triazoles as anti-tubercular agent
Anindra Sharma, Anand K. Agrahari, Sanchayita Rajkhowa, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114454-114454
Closed Access | Times Cited: 54

Scroll to top